Scottish Pain Research Community (SPaRC) Annual Scientific

This event is approved by the
Royal College of Anaesthetists
for 5 CPD credits
Scottish Pain Research Community (SPaRC)
Annual Scientific Meeting
Friday 27th March 2015
West Park Conference Centre, Dundee
9:00 – 10:00
Registration/coffee/networking – Sidlaw Auditorium Foyer
Chair: Dr Lesley Colvin, Acting Chair of Chronic Pain Research Subgroup,
Consultant/ Reader in Anaesthesia and Pain Medicine, Western General Hospital, Edinburgh
10:00 – 10:05
Welcome and introduction to the Scottish Pain Research Community
(SPaRC) 5th Annual Scientific Meeting
Dr Lesley Colvin, Acting Chair of Chronic Pain Research Subgroup
10:05 – 10:15
Chronic Pain Provision in Scotland - A National Update 2014/2015
Mr Paul Cameron, National Chronic Pain Co-ordinator, Scottish Government
and Clinical Lead Physiotherapist, NHS Fife
10:15 – 10:45
Keynote Presentation 1:
Gain Control Mechanisms of Pain Sensitivity
Professor Rolf-Detlef Treede, Chair of Neurophysiology, Medical Faculty
Mannheim, University of Heidelberg
Session(1):
Chaired by Professor Tim Hales, Professor and Director of the Division of
Neuroscience & the Institute of Academic Anaesthesia, University of Dundee
10:45 – 11:00
Chronic pain predicts reduced physical activity in a population cohort study –
Kathryn R Martin
11:00 – 11:15
Sex-dependent regulation of rat C-fibre activity-dependent slowing in
inflammatory pain– Allen C Dickie
11:15 – 11:30
Opioids use in primary care. Identifying indicators of good prescribing and
problem use in routinely collected electronic health data – Nicola Torrance
11:30 – 11:50
Coffee Break – Sidlaw Auditorium Foyer
Session(2):
Chaired by Dr Mick Serpell, Clinical Senior Lecturer (Anaesthesia), University
of Glasgow
11:50 – 12:05
Predictors of poor functional outcome in distal upper limb pain: The Arm Pain
Trial – Daniel Whibley
12:05 – 12:20
12:20 - 12:35
Brainstem processing of peripheral punctate stimulus is different between
patients who develop Chemotherapy Induced Peripheral Neuropathy (CIPN) as
compared to those who do not; a prospective cohort fMRI study –
Marta Seretny
Development and evaluation of an online training programme for primary care
staff to facilitate a shared understanding of symptom perpetuation in those
with Medically Unexplained Symptoms (MUS) and complex Long Term
Conditions (LTC) – David Craig
12:35 – 12:50
Self-Reported Chronic Pelvic Pain among Women - Abimbola Ayorinde
12:50 – 13:40
Lunch – Main Restaurant
Session(3):
Chaired by Professor Sue Fleetwood-Walker Chair of Sensory Neuroscience,
University of Edinburgh
13:40 – 13:50
Establishing an Intensive Residential Pain Management Programme in Scotland
Dr Martin Dunbar, Honorary Clinical Senior Lecturer (Institute of Health and
Wellbeing), University of Glasgow
13:50 – 14:05
Three year risk of emergency healthcare utilisation in a treatment-seeking,
opioid-dependent population with comorbid chronic pain –
Cassie Higgins
14:05 – 14:20
Mitochondria-targeted antioxidants attenuate paclitaxel-induced mechanical
hypersensitivity in vivo – Barry McCormick
14:20 – 15:15
Poster Viewing and Coffee Break – Poster authors to present their posters and
answer any questions from delegates – Sidlaw Auditorium Foyer
Session(4):
Chaired by Professor Gary Macfarlane, Chair in Epidemiology (Clin),
University of Aberdeen
15:15 – 15:30
How do chronic pain patients on strong opioids score on quality of life
measures? - Joanna Renée
15:30 – 15:45
Barriers to self-management of chronic pain in primary care – Katy Gordon
15:45 – 16:15
16:15 – 16:20
Keynote Presentation 2:
Musculoskeletal pain of the foot: does it work well under pressure?
Dr Gordon Hendry, Institute for Applied Health Research, School of Health
and Life Sciences, Glasgow Caledonian University
Next Steps and Closing Remarks
Dr Lesley Colvin, Acting Chair of Chronic Pain Research Subgroup
This event is financially supported in accordance with the
ABPI Code of Practice for the Pharmaceutical Industry.
The University of Dundee is grateful to the ABPI Scotland
Pain Industry Group for kindly agreeing to support
the running costs of this meeting.
The ABPI Scotland Pain Industry Group comprises the following companies operating for
the benefit of patients in Scotland: Astellas, Grunenthal, Pfizer, Napp